thats a fair point. Incidence of 5 per 100k on about 1bil so roughly 50,000. Probably 100k patients total each year new and existing as a rough estimate. Putting that into perspective 240 patients especially for this drug, which can be presumed safe for all intents and purposes. Is it then a possibility that this trial could finish registration in 6 months or so? would love to hear your thoughts @arkangel256 and @JabraD and others
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.237M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28352 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 8998 | 1 |
View Market Depth
| Last trade - 16.21pm 28/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable